ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993

Senators Urge study section On Clinical Cancer Research

February 4, 1994

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985